1. Home
  2. NCMI vs MASS Comparison

NCMI vs MASS Comparison

Compare NCMI & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

HOLD

Current Price

$3.40

Market Cap

306.0M

ML Signal

HOLD

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$6.60

Market Cap

251.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCMI
MASS
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
306.0M
251.9M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
NCMI
MASS
Price
$3.40
$6.60
Analyst Decision
Buy
Buy
Analyst Count
4
1
Target Price
$5.63
$12.00
AVG Volume (30 Days)
420.0K
228.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
3.36%
N/A
EPS Growth
52.17
125.47
EPS
N/A
0.54
Revenue
N/A
$56,197,000.00
Revenue This Year
$11.20
$19.44
Revenue Next Year
$6.22
$18.63
P/E Ratio
N/A
$12.61
Revenue Growth
N/A
N/A
52 Week Low
$2.92
$4.20
52 Week High
$5.88
$9.34

Technical Indicators

Market Signals
Indicator
NCMI
MASS
Relative Strength Index (RSI) 47.03 45.24
Support Level $3.17 $5.86
Resistance Level $3.77 $6.66
Average True Range (ATR) 0.13 0.35
MACD -0.01 -0.07
Stochastic Oscillator 9.72 13.24

Price Performance

Historical Comparison
NCMI
MASS

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: